Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease (Q45710733)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 1, 2003
edit
Language Label Description Also known as
English
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
scientific article published on October 1, 2003

    Statements

    Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease (English)
    Cardiac Synagis Study Group
    1 October 2003
    532-540

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit